Pediatrics, Pediatric Pulmonology · Boston, MA
NPI
1174556062
Since 2006
Specialty
Pediatrics, Pediatric Pulmonology
Code 2080P0214X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Longwood Ave, Children's Hospital Boston, Mailstop 208
Boston, MA, 02115
Phone (617) 355-6105
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
166 services
Medicare patients, 2024
70
Average age 39
Drug cost, 2024
$3.0M
453 prescriptions
Company payments, 2025
$35K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmet Uluer was code 99215 (office e&m - established), 54 times for 32 patients. In total Ahmet Uluer billed 166 services in 16 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 54 | 32 | $135.01 | $7,290 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 11 | $65.59 | $2,230 |
| 99211 Office E&M - Established | Office | 20 | 19 | $16.83 | $337 |
| 99214 Office E&M - Established | Office | 15 | 13 | $92.77 | $1,392 |
By year: 2022 $16K for 175 services; 2023 $16K for 166 services; 2024 $15K for 166 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmet Uluer prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 79 prescriptions and refills. In total Ahmet Uluer wrote 453 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 79 | 82 | 12 | $2.2M |
| Creon Lipase/Protease/Amylase | 35 | 53 | Under 11 | $399K |
| Azithromycin Generic | 25 | 48 | Under 11 | $786 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 25 | 28 | Under 11 | $1,408 |
| Famotidine Generic | 16 | 39 | Under 11 | $427 |
| Zenpep Lipase/Protease/Amylase | 14 | 16 | Under 11 | $108K |
| Levofloxacin Generic | 13 | 13 | Under 11 | $170 |
| Pancreaze Lipase/Protease/Amylase | 13 | 19 | Under 11 | $127K |
| Omeprazole Generic | 12 | 28 | Under 11 | $370 |
| Mupirocin Generic | 12 | 12 | Under 11 | $61.92 |
| Aprepitant Generic | 11 | 11 | Under 11 | $15K |
| Trazodone Hcl Generic | 11 | 21 | Under 11 | $108 |
| Ciprofloxacin Hcl Generic | 11 | 11 | Under 11 | $145 |
Brand drugs: - claims; generic drugs: 250 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmet Uluer $35K ($35K in general payments such as food, travel and fees) from 2 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $31K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.